13: The Outcome of Allogeneic Stem Cell Transplantation (alloSCT) for the Treatment of Therapy-Related Myelodysplastic Syndrome (tMDS) and Acute Myeloid Leukemia (tAML) Varies Considerably by Risk Factor: An Observational Study From the Center for International Blood and Marrow Transplant Research (CIBMTR) | Publicación